Sheng‐Ping Yang

3.8k total citations · 1 hit paper
115 papers, 3.2k citations indexed

About

Sheng‐Ping Yang is a scholar working on Molecular Biology, Organic Chemistry and Plant Science. According to data from OpenAlex, Sheng‐Ping Yang has authored 115 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 19 papers in Organic Chemistry and 19 papers in Plant Science. Recurrent topics in Sheng‐Ping Yang's work include Phytochemical compounds biological activities (37 papers), Natural product bioactivities and synthesis (32 papers) and Sesquiterpenes and Asteraceae Studies (17 papers). Sheng‐Ping Yang is often cited by papers focused on Phytochemical compounds biological activities (37 papers), Natural product bioactivities and synthesis (32 papers) and Sesquiterpenes and Asteraceae Studies (17 papers). Sheng‐Ping Yang collaborates with scholars based in China, United States and Australia. Sheng‐Ping Yang's co-authors include Jian‐Min Yue, Yan Wu, Chuan‐Rui Zhang, Shang‐Gao Liao, Huadong Chen, Huabin Hu, Jian Ding, Cheng‐Qi Fan, Tao Yuan and Quan Li and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Sheng‐Ping Yang

113 papers receiving 3.1k citations

Hit Papers

How does the development of digital financial inclusion a... 2022 2026 2023 2024 2022 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheng‐Ping Yang China 38 1.9k 742 656 487 465 115 3.2k
Curtis Hose United States 22 2.3k 1.2× 1.6k 2.2× 344 0.5× 343 0.7× 328 0.7× 31 4.7k
Daniel D. Lantvit United States 31 1.4k 0.7× 315 0.4× 364 0.6× 245 0.5× 275 0.6× 88 2.8k
Shashi Bhushan India 37 1.5k 0.8× 866 1.2× 373 0.6× 213 0.4× 252 0.5× 162 3.9k
Daniel Guénard France 36 1.6k 0.8× 2.4k 3.2× 210 0.3× 538 1.1× 188 0.4× 97 4.9k
Yuan Gao China 30 753 0.4× 792 1.1× 446 0.7× 189 0.4× 122 0.3× 144 2.6k
Shengtao Xu China 34 1.9k 1.0× 1.3k 1.7× 140 0.2× 394 0.8× 130 0.3× 127 3.3k
Yong Qin China 37 1.5k 0.8× 3.5k 4.7× 213 0.3× 1.1k 2.2× 213 0.5× 181 5.3k
Eun‐Ryeong Hahm United States 35 1.8k 0.9× 288 0.4× 447 0.7× 193 0.4× 385 0.8× 84 3.2k
Hyen Joo Park South Korea 31 1.5k 0.8× 568 0.8× 209 0.3× 169 0.3× 413 0.9× 74 2.6k
Jong Seok Lee South Korea 31 918 0.5× 490 0.7× 550 0.8× 204 0.4× 139 0.3× 131 3.0k

Countries citing papers authored by Sheng‐Ping Yang

Since Specialization
Citations

This map shows the geographic impact of Sheng‐Ping Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng‐Ping Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng‐Ping Yang more than expected).

Fields of papers citing papers by Sheng‐Ping Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng‐Ping Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng‐Ping Yang. The network helps show where Sheng‐Ping Yang may publish in the future.

Co-authorship network of co-authors of Sheng‐Ping Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng‐Ping Yang. A scholar is included among the top collaborators of Sheng‐Ping Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng‐Ping Yang. Sheng‐Ping Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Sheng‐Ping, et al.. (2024). Enzymatically modified isoquercitrin and its protective effects against photoaging: In‐vitro and clinical studies. Photochemistry and Photobiology. 100(5). 1475–1488. 2 indexed citations
2.
Yang, Sheng‐Ping & Gilbert Berdine. (2023). Trial sequential analysis. The Southwest Respiratory and Critical Care Chronicles. 11(47). 63–67. 3 indexed citations
3.
Zhang, Zhilong, et al.. (2023). Frequency of osteoporosis in Chinese patients with rheumatoid arthritis: a meta-analysis. Archives of Osteoporosis. 18(1). 24–24. 6 indexed citations
4.
Jia, Jia, Jun Wu, Xi Wang, et al.. (2022). Iboga-type alkaloids with Indolizidino[8,7-b]Indole scaffold and bisindole alkaloids from Tabernaemontana bufalina Lour. Phytochemistry. 196. 113089–113089. 5 indexed citations
5.
Cai, You‐Sheng, Cong Wang, Ling Chen, et al.. (2019). Octahydro-Protoberberine and Protoemetine-Type Alkaloids from the Stems of Alangium salviifolium and Their Cytotoxicity. Journal of Natural Products. 82(9). 2645–2652. 15 indexed citations
6.
Yang, Sheng‐Ping, et al.. (2017). A systematic review of unilateral versus bilateral percutaneous vertebroplasty/percutaneous kyphoplasty for osteoporotic vertebral compression fractures. Acta Orthopaedica et Traumatologica Turcica. 51(4). 290–297. 29 indexed citations
7.
Baş, Hatice, Kazım Başer, & Sheng‐Ping Yang. (2016). Acute kidney injury associated with concomitant use of vancomycin with piperacillin-tazobactam: a focused review and meta-analysis. The Southwest Respiratory and Critical Care Chronicles. 4(15). 32–37. 1 indexed citations
8.
Yang, Sheng‐Ping, et al.. (2012). A systematic review of growth hormone for hip fractures. Growth Hormone & IGF Research. 22(3-4). 97–101. 8 indexed citations
9.
Liu, Jia, Sheng‐Ping Yang, Gang Ni, Yu‐Cheng Gu, & Jian‐Min Yue. (2012). Triterpenoids fromAglaia odoratavar.microphyllina. Journal of Asian Natural Products Research. 14(10). 929–939. 10 indexed citations
10.
Yang, Sheng‐Ping, et al.. (2011). STUDENT ETHICAL AWARENESS AND BUSINESS PROGRAM MATRICULATION: EVIDENCE FROM THE U.S. SSRN Electronic Journal. 3(1). 41–49. 4 indexed citations
11.
Liu, Yali, et al.. (2011). Risk of Bias Tool in Systematic Reviews/Meta-Analyses of Acupuncture in Chinese Journals. PLoS ONE. 6(12). e28130–e28130. 13 indexed citations
12.
Liu, Jia, et al.. (2011). Limonoids from the stems of Toona ciliata var. henryi (Meliaceae). Phytochemistry. 72(17). 2189–2196. 30 indexed citations
13.
McSweeney, Jean C., et al.. (2010). Cluster Analysis of Women's Prodromal and Acute Myocardial Infarction Symptoms by Race and Other Characteristics. The Journal of Cardiovascular Nursing. 25(4). 311–322. 51 indexed citations
14.
Yuan, Tao, Sheng‐Ping Yang, Haiyan Zhang, et al.. (2009). Phenolic compounds with cell protective activity from the fruits ofLivistona chinensis. Journal of Asian Natural Products Research. 11(3). 243–249. 19 indexed citations
15.
Yang, Sheng‐Ping, et al.. (2008). COMMUTING AND WAGES IN THE BLACK HILLS OF SOUTH DAKOTA AND WYOMING. 9(1). 7. 1 indexed citations
16.
Zhang, Chuan‐Rui, Sheng‐Ping Yang, & Jian‐Min Yue. (2008). Sterols and triterpenoids from the spores ofGanoderma lucidum. Natural Product Research. 22(13). 1137–1142. 28 indexed citations
17.
Yang, Sheng‐Ping, et al.. (2008). Terpenoids from Dysoxylum densiflorum. Phytochemistry. 69(17). 2993–2997. 47 indexed citations
18.
Yang, Sheng‐Ping, Zhaobing Gao, Yan Wu, Guo‐Yuan Hu, & Jian‐Min Yue. (2008). Chlorahololides C–F: a new class of potent and selective potassium channel blockers from Chloranthus holostegius. Tetrahedron. 64(9). 2027–2034. 73 indexed citations
19.
Fan, Cheng‐Qi, et al.. (2004). Novel Antibacterial Diterpenoids from Larix chinensis Beissn. Chemistry & Biodiversity. 1(11). 1702–1707. 16 indexed citations
20.
Yang, Sheng‐Ping, Ying Wang, Yan Wu, & Jian‐Min Yue. (2004). Chemical constituents fromPseudolarix Kaempferi. Natural Product Research. 18(5). 439–446. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026